Merit Medical Systems Cash Flow Statement
NASDAQ: MMSIHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Merit Medical Systems free cash flow
In fiscal 2025, Merit Medical Systems generated $297.4 million of operating cash flow and spent $81.7 million on capital expenditures. That left free cash flow of $215.7 million, a free-cash-flow margin of 14.2% of revenue. Free cash flow was up 16.2% from the prior year's $185.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Merit Medical Systems cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 128.49M | 120.36M | 94.41M | 74.52M | 48.45M | -9.84M | 5.45M | 42.02M | 27.52M | 20.12M |
| Net Income growth (YoY) | +6.76% | +27.48% | +26.70% | +53.79% | — | -280.57% | -87.03% | +52.66% | +36.79% | -15.47% |
| Depreciation & Amortization | 123.17M | 102.71M | 89.98M | 81.80M | 84.07M | 94.07M | 92.10M | 69.55M | 53.58M | 43.76M |
| Stock-Based Compensation | 43.46M | 28.47M | 21.33M | 18.04M | 16.09M | 14.34M | 9.38M | 6.12M | 4.08M | 2.51M |
| Change in Working Capital | -30.58M | -23.32M | -59.82M | -49.45M | -30.28M | 40.28M | -49.12M | -39.84M | -31.49M | -21.27M |
| Operating Cash Flow | 297.37M | 220.80M | 145.15M | 114.29M | 147.23M | 165.27M | 77.81M | 86.53M | 62.73M | 53.60M |
| Capital Expenditures | -81.72M | -35.14M | -34.29M | -45.03M | -27.94M | -45.99M | -78.17M | -63.32M | -38.62M | -32.84M |
| Investing Cash Flow | -247.39M | -368.65M | -175.35M | -57.40M | -37.16M | -58.65M | -134.48M | -378.82M | -146.76M | -159.11M |
| Debt Issued | — | — | 1.20B | 215.21M | 98.42M | 68.63M | 246.66M | 639.11M | 197.21M | 219.50M |
| Debt Repaid | — | -99.06M | -579.62M | -260.14M | -206.92M | -157.00M | -202.16M | -522.61M | -243.21M | -102.10M |
| Financing Cash Flow | 16.00M | -60.01M | 559.27M | -60.26M | -98.44M | -95.71M | 33.53M | 328.28M | 96.52M | 121.09M |
| Net Change in Cash | 69.78M | -210.38M | 528.59M | -7.19M | 10.83M | 12.60M | -23.04M | 35.02M | 13.16M | 14.99M |
| Free Cash Flow | 215.66M | 185.66M | 110.86M | 69.26M | 119.29M | 119.28M | -360.00K | 23.21M | 24.10M | 20.76M |
This table shows 10 annual periods of Merit Medical Systems's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MMSI's reporting calendar. What is a cash flow statement?